Search the record
clear ✕
18 results
Hearing Business meeting to consider S.2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, S.4189, to...
senate Health, Education, Labor, and Pensions Committee · Jul 22, 2026 · Transcript · 4 transcript matches
PAUL, RAND "Biologics are only 5% of prescriptions but account for 51% of spending. My bill seeks to reduce the cost of biologic drugs by removing the blanket requirement for comparative efficacy trials in biosimilar development, which are often unnecessary. These trials are like stage three trials that attempt to gauge whether biosimilar and the reference biologic are equally effective, but a review of over 600 studies published in the journal Pharmaceuticals found that no biosimilar with proven analytical similarity has ever failed a comparative efficacy study. These trials are like stage three trials..."
CRS Report
Circuit Split over the Food and Drug Administration’s Denial of Applications Seeking to Market Flavored E-Cigarettes, Part 2 of 2
Posts · Apr 5, 2024
This two-part Sidebar examines the circuit split over certain electronic nicotine delivery system (ENDS) products—that is, products with many common names, such as e-cigarettes and vape pens—that...
Testimony PAUL, RAND
Business meeting to consider S.2355, to amend the Public Health Servic...
senate Health, Education, Labor, and Pensions Committee · Jul 22, 2026
"Biologics are only 5% of prescriptions but account for 51% of spending. My bill seeks to reduce the cost of biologic drugs by removing the blanket requirement for comparative efficacy trials in biosimilar development, which are often unnecessary. These trials are like stage three trials that attempt to gauge whether biosimilar and the reference biologic are equally effective, but a review of over 600 studies published in the journal Pharmaceuticals found that no biosimilar with proven..."
Testimony PAUL, RAND
Business meeting to consider S.2355, to amend the Public Health Servic...
senate Health, Education, Labor, and Pensions Committee · Jul 22, 2026
"The FDA has realized that these burdensome nature of these studies and its recent guidance, the agency waived comparative efficacy studies for therapeutic proteins like monoclonal antibodies. We've worked with the FDA on this bill because when a biosimilar is proven to be safe and effective, there's no reason to delay care to patients and regulatory certainty to"
CRS Report
Recent Supreme Court Decisions Related to ECigarette Regulation
Posts · Jul 3, 2025
In its most recent term, the Supreme Court considered two cases related to the implementation of the Family Smoking Prevention and Tobacco Control Act of 2009 (TCA, P.L. 111-31) as applied to certain...
CRS Report
U.S. Regulation of Chinese Stocks: Legal Background and Regulatory Options
Posts · Sep 21, 2020
Tensions between the United States and China have again moved to center stage. In recent weeks, the Trump Administration has ordered China to close its Houston consulate over allegations of economic...
CRS Report
Immigration and Customs Enforcement (ICE) and the Non-Detained Docket (NDD)
InFocus · Apr 24, 2026
Background The Immigration and Nationality Act (INA, Title 8 of the U.S. Code) authorizes and sometimes requires the U.S. Department of Homeland Security (DHS) to detain aliens (foreign nationals)...
CRS Report
Mission Critical: Restoring National Security as the Focus of Defense Production Act Reauthorization
Testimony · Mar 12, 2024
Type here to begin keywords
CRS Report
Economic Growth Approaches in U.S. Foreign Assistance
Reports · Jan 12, 2022
U.S. assistance for economic growth has declined as a share of total foreign assistance for international development over the course of the 21st century. However, several high-profile foreign aid...
CRS Report
Tax-Advantaged Savings Accounts: Overview and Policy Considerations
Reports · Mar 31, 2023
Congress has created a variety of tax-advantaged savings accounts to encourage taxpayers to save for certain expenses. These accounts are some of the largest benefits administered through the United...
CRS Report
Military Medical Care: Frequently Asked Questions
Reports · Oct 25, 2021
Military medical care is a congressionally authorized entitlement that has expanded in size and scope since the late 19th century. Chapters 55 and 56 of Title 10, U.S. Code entitle certain health...
CRS Report
Extending Unemployment Compensation Benefits During Recessions
Reports · Oct 1, 2014
This report describes the history of temporary federal extensions to unemployment benefits from 1980 to the present. Among these extensions is the Emergency Unemployment Compensation (EUC08) program...
CRS Report
How FDA Approves Drugs and Regulates Their Safety and Effectiveness
Reports · May 8, 2018
The Food and Drug Administration (FDA), a regulatory agency within the Department of Health and Human Services, regulates the safety and effectiveness of drugs sold in the United States. FDA divides...
CRS Report
Dual-Use Solar Photovoltaics: Emerging Applications and Issues for Congress
Reports · Oct 3, 2024
Solar photovoltaics (PV) is one potential renewable energy technology that may help the United States achieve its carbon reduction goals and commitments. However, solar PV uses more land per megawatt...
CRS Report
Vaccine Safety in the United States: Overview and Considerations for COVID-19 Vaccines
Reports · Jan 29, 2021
Widespread immunization efforts have been linked to increased life expectancy and reduced illness. U.S. vaccination programs, headed by the Centers for Disease Control and Prevention (CDC) within the...
CRS Report
Water Infrastructure for the 21st Century: The Viability of Incorporating Natural Infrastructure in Bureau of Reclamation Water Management Systems
Testimony · Mar 24, 2021
water resource; U.S. Bureau of Reclamation; natural infrastructure; nature-based infrastructure; groundwater storage; aquifer recharge; watershed restoration
CRS Report
Deferred Maintenance and Repair at Civilian Agencies: Causes, Risks, and Policy Options
Reports · Oct 4, 2024
Federal civilian agencies own more than 285,000 buildings and structures, which have been acquired over time to help the government achieve its objectives. As these assets age, their component...
CRS Report
U.S. Farm Income Outlook: 2021 Forecast
Reports · Mar 14, 2022
The U.S. Department of Agriculture’s (USDA’s) Economic Research Service (ERS) forecasts that U.S. farm profitability—as measured by net farm income and net cash income—increased in 2021 for the third...